| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.0046 | 0.9 |